Results

Total Results: 1,545 records

Showing results for "listed".

  1. effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
    May 31, 2016 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … been much more appropriate to categorize the outcomes according to the four categories of outcomes listed … We have edited Table 6 to be consistent with the four categories of outcomes listed in KQ 2. … In addition, the four categories of outcomes listed in KQ 2 are clearly organized to distinguish leading
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … [page vii] SGAs as a class (and risperidone individual); (and risperidone individually) would be listed … placebo-Description of long term studies- risperidone vs placebo - There was a 3rd arm to this study92 that is not listed … The major AEs should be listed in parentheses as some patients may have discontinued but were not necessarily
  3. effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … [page vii] SGAs as a class (and risperidone individual); (and risperidone individually) would be listed … placebo-Description of long term studies- risperidone vs placebo - There was a 3rd arm to this study92 that is not listed … The major AEs should be listed in parentheses as some patients may have discontinued but were not necessarily
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-protocol.pdf
    July 27, 2023 - Potential questions for KIs are listed below: Questions for providers, researchers, and policymakers
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
    November 01, 2012 - narrowed or refined. 10 Citations for the most recent, relevant systematic reviews should be listed … organization and agency Web sites described above under Existing Guidance Documentation should be listed
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
    March 01, 2012 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … In the summary table, both oxcarbazepine and lacosamide are listed as working via "Na+ channel inhibition … Section Comment Response Peer Reviewer #3 Methods The chosen outcomes for this review are simply listed … In some instances the order in which the performance of PB, LEV and LTG are listed on various cognitive … In some instances the order in which the performance of PB, LEV and LTG are listed on various cognitive
  7. effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - ThromboGenics announced the U.S. launch of Jetrea and listed the price for a single-use glass vial … The ReWalk-I (institutional use) system is FDA-listed for institutional use only, and reported costs … patient per month for dimethyl fumarate.17 For benchmarking purposes, the oral MS drug fingolimod was listed … cost of one 30-mg dose of ecallantide (Kalbitor®), a recently approved competitor to icatibant, was listed … Contraindications listed by the manufacturer include optic nerve disease, central artery or vein occlusion
  8. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - -based, online aggregator of prescription-drug prices, GoodRx, listed pricing for 30-day supplies ranging … About one-third of surveyed primary care physicians listed one of these GLP-1 analogs as the obesity … by the FDA.”63 But several experts expressed concern regarding gastrointestinal side effects and listed … be a deterrent to patient acceptance.65 Other notable barriers to wide acceptance of liraglutide listed … Several experts listed patient education and training to have a potentially minor impact.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
    August 01, 2016 - Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence Focus of This Summary This is a summar…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-pregnant-protocol.pdf
    August 24, 2023 - modalities To be included, studies must evaluate one or more nonpharmacological modalities such as those listed … uncommonly-analyzed comparisons of interventions for depression and anxiety treatments will be listed
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
    December 11, 2012 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … Data reported in the papers is listed as absent if not conforming to arbitrary criteria: means vs. medians … include all relevant data with footnotes or other delineation if the reported data deviated from the listed
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_research-protocol.pdf
    June 10, 2013 - major headings and limiting our search to English-language and human- only studies; relevant terms are listed … Appropriateness will be determined by the same methods listed above. Table 2. … Planned stratifications or categories for subgroup analyses include those listed in KQs 3, 4, and 5.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
    September 18, 2012 - Vaccinations recommended by the Centers for Disease Control and Prevention (CDC) in 2011 are listed … (See the comparisons listed under Criteria for Inclusion/Exclusion of Studies in the Review.)
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/suda-final-protocol.pdf
    October 02, 2018 - Studies in the Review Please refer to Section II, The Key Questions, where the Eligibility Criteria are listed … may also conduct meta-regression analyses to evaluate study, patient, and intervention features, (as listed
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
    October 07, 2011 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … We agree and have added text under KQ2 and have listed this important outcome in the future research
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
    March 01, 2012 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … colonization and infection are considered equivalent (line 34) which is not in keeping with the definition listed … Methods Page 41, line 38: additional variables have been associated with severity of CDI than those listed … studies plus 26 from hand searching and 3 from testing - adds up to 98, in the flow diagram - it is listed
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_disposition-comments.pdf
    April 02, 2013 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … These suggestions are listed in the sections on Applicability and Research Gaps. … Some of the listed outcomes are vague (e.g., resilience).
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-interventions-disposition.pdf
    May 26, 2017 - Each comment is listed with the name and affiliation of the commentator, if this information is provided … journal and used in a cited Cochrane review (Gattino et al., Nordic Journal of Music Therapy, 2011; not listed
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
    February 01, 2015 - indicated that the literature search, in terms of electronic databases, was limited; however, most listed … databases varied considerably from 2 databases to “any and all” depending on the topic; the majority listed … searches as comprehensive, one limited searches to 3 electronic databases, and the other products listed
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
    January 01, 2020 - We located key informants from frequently listed and cited authors of relevant literature, Internet … The distribution of studies using these types of platforms is listed in Table 2. … States.21,31,52,71 The tri-planar platform has been used in only one study thus far.57 Two studies listed … 72 weeks Outcomes The distribution of outcomes assessed in the 12 whole-body vibration studies is listed … informants mentioned that the effects of whole-body vibration are unknown for some individuals, and they listed

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: